The latest price target for Progyny (NASDAQ:PGNY) was reported by Canaccord Genuity on September 20, 2024. The analyst firm set a price target for $18.00 expecting PGNY to rise to within 12 months (a possible 7.85% upside). 31 analyst firms have reported ratings in the last year.

The latest analyst rating for Progyny (NASDAQ:PGNY) was provided by Canaccord Genuity, and Progyny maintained their hold rating.

There is no last upgrade for Progyny

The last downgrade for Progyny Inc happened on September 19, 2024 when JMP Securities changed their price target from N/A to N/A for Progyny Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Progyny, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Progyny was filed on September 20, 2024 so you should expect the next rating to be made available sometime around September 20, 2025.

While ratings are subjective and will change, the latest Progyny (PGNY) rating was a maintained with a price target of $24.00 to $18.00. The current price Progyny (PGNY) is trading at is $16.69, which is out of the analyst’s predicted range.